BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Swetha R, Kumar D, Gupta SK, Ganeshpurkar A, Singh R, Gutti G, Kumar D, Jana S, Krishnamurthy S, Singh SK. Multifunctional hybrid sulfonamides as novel therapeutic agents for Alzheimer’s disease. Future Medicinal Chemistry 2019;11:3161-78. [DOI: 10.4155/fmc-2019-0106] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang H, Peng Y, Zhuo L, Wang Y, Zeng G, Wang S, Long L, Li X, Wang Z. Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy. Eur J Med Chem 2022;242:114695. [PMID: 36044812 DOI: 10.1016/j.ejmech.2022.114695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ganeshpurkar A, Singh R, Kumar D, Gutti G, Gore P, Sahu B, Kumar A, Singh SK. Identification of sulfonamide-based butyrylcholinesterase inhibitors using machine learning. Future Med Chem 2022;14:1049-70. [PMID: 35707942 DOI: 10.4155/fmc-2021-0325] [Reference Citation Analysis]
3 Xie Y, Wang Y, Jiang S, Xiang X, Wang J, Ning L. Novel strategies for the fight of Alzheimer's disease targeting amyloid-β protein. J Drug Target 2021;:1-10. [PMID: 34435898 DOI: 10.1080/1061186X.2021.1973482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ganeshpurkar A, Singh R, Shivhare S, Divya, Kumar D, Gutti G, Singh R, Kumar A, Singh SK. Improved machine learning scoring functions for identification of Electrophorus electricus's acetylcholinesterase inhibitors. Mol Divers 2021. [PMID: 34328603 DOI: 10.1007/s11030-021-10280-w] [Reference Citation Analysis]
5 Taha M, Alshamrani FJ, Rahim F, Anouar EH, Uddin N, Chigurupati S, Almandil NB, Farooq RK, Iqbal N, Aldubayan M, Venugopal V, Khan KM. Synthesis, characterization, biological evaluation, and kinetic study of indole base sulfonamide derivatives as acetylcholinesterase inhibitors in search of potent anti-Alzheimer agent. Journal of King Saud University - Science 2021;33:101401. [DOI: 10.1016/j.jksus.2021.101401] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
6 He Y, Li S, Mbaezue II, Reddy AC, Tsantrizos YS. Copper-boryl mediated transfer hydrogenation of N-sulfonyl imines using methanol as the hydrogen donor. Tetrahedron 2021;85:132063. [DOI: 10.1016/j.tet.2021.132063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Shaikh S, Pavale G, Dhavan P, Singh P, Uparkar J, Vaidya SP, Jadhav BL, Ramana MMV. Design, synthesis and evaluation of dihydropyranoindole derivatives as potential cholinesterase inhibitors against Alzheimer's disease. Bioorg Chem 2021;110:104770. [PMID: 33667902 DOI: 10.1016/j.bioorg.2021.104770] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
8 Kowalik M, Brzeski J, Gawrońska M, Kazimierczuk K, Makowski M. Experimental and theoretical investigation of conformational states and noncovalent interactions in crystalline sulfonamides with a methoxyphenyl moiety. CrystEngComm 2021;23:6137-62. [DOI: 10.1039/d1ce00869b] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
9 Makhaeva GF, Kovaleva NV, Boltneva NP, Lushchekina SV, Astakhova TY, Rudakova EV, Proshin AN, Serkov IV, Radchenko EV, Palyulin VA, Bachurin SO, Richardson RJ. New Hybrids of 4-Amino-2,3-polymethylene-quinoline and p-Tolylsulfonamide as Dual Inhibitors of Acetyl- and Butyrylcholinesterase and Potential Multifunctional Agents for Alzheimer's Disease Treatment. Molecules 2020;25:E3915. [PMID: 32867324 DOI: 10.3390/molecules25173915] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
10 Zipfel P, Rochais C, Baranger K, Rivera S, Dallemagne P. Matrix Metalloproteinases as New Targets in Alzheimer's Disease: Opportunities and Challenges. J Med Chem. 2020;63:10705-10725. [PMID: 32459966 DOI: 10.1021/acs.jmedchem.0c00352] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]